Form 4: Alkermes EVP Blair Curtis Jackson Reports Stock Transactions
SEC Form 4 Filing
EVP, Chief Operating Officer of Alkermes plc, Blair Curtis Jackson, reports acquisition and disposal of ordinary shares and restricted stock units.
Summary
- Blair Curtis Jackson, EVP, Chief Operating Officer of Alkermes plc, filed a Form 4.
- The filing reports transactions involving Alkermes plc ordinary shares and restricted stock units.
- On February 26, 2025, Jackson acquired 8,322 ordinary shares through the vesting of restricted stock units.
- Also on February 26, 2025, Jackson disposed of 3,695 ordinary shares at a price of $34.795 per share to cover tax obligations.
- Following these transactions, Jackson directly owns 201,368 ordinary shares and 24,967 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common in the pharmaceutical industry.
Key Dates
| Date | Description |
|---|---|
| 02/26/2025 | Date of earliest transaction: acquisition of shares via restricted stock unit vesting and disposal of shares for tax obligations. |
| 02/28/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.